Literature DB >> 23983933

The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement.

Ahmed Mahmoud1, Karen P Hayhurst, Richard J Drake, Shôn W Lewis, Thomas R E Barnes.   

Abstract

Antipsychotic nonneurological side effects, such as sexual dysfunction, can adversely affect the quality of patients' relationships, their treatment adherence and their quality of life. In the UK CUtLASS (Cost Utility of the Latest Antipsychotics in Severe Schizophrenia) study, nonneurological side effects were assessed using the ANNSERSv1 (Antipsychotic Non-Neurological Side Effects Rating Scale version 1), a new scale to assess the side effects associated with both first- and second-generation antipsychotic drugs. A total of 26 participants also completed the Derogatis Interview for Sexual Functioning (self-report version, DISF-SR). A statistically significant, and specific, correlation was found between scores on the DISF-SR and the sexual side-effect section of the ANNSERS at baseline. The sexual side-effects subscale of the ANNSERS is a valid measure of sexual dysfunction in the treatment of schizophrenia.

Entities:  

Keywords:  adverse effects; antipsychotics; assessment; schizophrenia; sexual dysfunction

Year:  2011        PMID： 23983933      PMCID： PMC3736922          DOI： 10.1177/2045125311417041

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


  9 in total

1.  The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): an introductory report.

Authors:  L R Derogatis
Journal:  J Sex Marital Ther       Date:  1997

2.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Authors:  Peter B Jones; Thomas R E Barnes; Linda Davies; Graham Dunn; Helen Lloyd; Karen P Hayhurst; Robin M Murray; Alison Markwick; Shôn W Lewis
Journal:  Arch Gen Psychiatry       Date:  2006-10

3.  Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

Authors:  M Lambert; P Conus; P Eide; R Mass; A Karow; S Moritz; D Golks; D Naber
Journal:  Eur Psychiatry       Date:  2004-11       Impact factor: 5.361

4.  Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.

Authors:  J Karagianis; D Novick; J Pecenak; J M Haro; M Dossenbach; T Treuer; W Montgomery; R Walton; A J Lowry
Journal:  Int J Clin Pract       Date:  2009-09-19       Impact factor: 2.503

5.  Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.

Authors:  Shôn W Lewis; Thomas R E Barnes; Linda Davies; Robin M Murray; Graham Dunn; Karen P Hayhurst; Alison Markwick; Helen Lloyd; Peter B Jones
Journal:  Schizophr Bull       Date:  2006-03-15       Impact factor: 9.306

6.  Subjective utility ratings of neuroleptics in treating schizophrenia.

Authors:  S E Finn; J M Bailey; R T Schultz; R Faber
Journal:  Psychol Med       Date:  1990-11       Impact factor: 7.723

7.  Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine.

Authors:  R I Ohlsen; R Williamson; B Yusufi; J Mullan; D Irving; S Mukherjee; E Page; K J Aitchison; T R E Barnes
Journal:  J Psychopharmacol       Date:  2008-05       Impact factor: 4.153

8.  Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

Authors:  Babur Yusufi; Sujoy Mukherjee; Robert Flanagan; Carol Paton; Graham Dunn; Eleanor Page; Thomas R E Barnes
Journal:  Int Clin Psychopharmacol       Date:  2007-07       Impact factor: 1.659

9.  Change in sexual dysfunction with aripiprazole: a switching or add-on study.

Authors:  Amna Mir; Kuppuswami Shivakumar; Richard J Williamson; Victoria McAllister; Veronica O'Keane; Katherine J Aitchison
Journal:  J Psychopharmacol       Date:  2008-05       Impact factor: 4.153
  9 in total
  3 in total

1.  Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study.

Authors:  Cicek Hocaoglu; Fatmagul H Celik; Gokhan Kandemir; Hulya Guveli; Bulent Bahceci
Journal:  Shanghai Arch Psychiatry       Date:  2014-12

Review 2.  Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Rubén de Alarcón; Nieves Prieto; José Mª Acosta; Bárbara Buch; Laura Montejo
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

3.  Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders.

Authors:  Alessandro Rodolico; Carmen Concerto; Alessia Ciancio; Spyridon Siafis; Laura Fusar-Poli; Carla Benedicta Romano; Elisa Vita Scavo; Antonino Petralia; Salvatore Salomone; Maria Salvina Signorelli; Stefan Leucht; Eugenio Aguglia
Journal:  Brain Sci       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.